Valneva SE (VALN) Other Non-Current Assets (2020 - 2026)

Valneva SE's (VALN) quarterly Other Non-Current Assets came in at $8.9 million in Q1 2026, up 1.0% year-on-year from $8.8 million in Q1 2025, and little changed quarter-over-quarter from $8.8 million in Q4 2025.

Valneva SE (VALN) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Valneva SE has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $8.9 million for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $8.9 million, up 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.9 million (up 1.0% YoY), and the FY2025 annual result was $8.8 million, up 2.82% from the prior year.
  • Other Non-Current Assets came in at $8.9 million for Q1 2026 at Valneva SE, roughly flat from $8.8 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $9.8 million in Q2 2025 to a low of $50505.2 in Q1 2022.
  • The 5-year median for Other Non-Current Assets is $8.7 million (2025), against an average of $7.3 million.
  • Across the five-year window, Other Non-Current Assets soared 18403.6% in 2022 and decreased 7.77% in 2025, its largest moves.
  • Valneva SE's Other Non-Current Assets stood at $8.5 million in 2022, then climbed by 7.89% to $9.1 million in 2023, then declined by 5.94% to $8.6 million in 2024, then advanced by 2.82% to $8.8 million in 2025, then rose by 0.4% to $8.9 million in 2026.
  • The last three Other Non-Current Assets figures came in at $8.9 million (Q1 2026), $8.8 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 289.41 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 60,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.26 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 8.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.87 Mn
Dec 31, 2025 8.84 Mn
Sep 30, 2025 8.68 Mn
Jun 30, 2025 9.77 Mn
Mar 31, 2025 8.78 Mn
Dec 31, 2024 8.59 Mn
Sep 30, 2024 8.30 Mn
Jun 30, 2024 9.74 Mn
Mar 31, 2024 9.52 Mn
Dec 31, 2023 9.13 Mn
Dec 31, 2022 8.47 Mn
Sep 30, 2022 2.98 Mn
Jun 30, 2022 51,218.72
Mar 31, 2022 50,505.20
Dec 31, 2021 45,758.84
Sep 30, 2021 50,709.35
Jun 30, 2021 50,579.40
Mar 31, 2021 51,868.15
Dec 31, 2020 48,883.88